Bringing you the latest Business News updates from the science industry
by Gwyneth Astles PAC Expands Presence in Asia Pacifi c
PAC, a leading global provider of advanced analytical instruments for laboratories and online process applications, recently welcomed Samuel Wong as the Vice-President of Sales for Asia Pacifi c. Mr Wong has over 25 years of sales experience in the oil and gas, marine, power generation, and transport industries. He joins PAC from AMOT where he was the Director of Sales for Asia Pacifi c since 2006. In this role, he had consistent revenue growth and also built out a commercial organisation in China that supports its Asia Pacifi c customer base. Prior to joining AMOT, Mr Wong worked for United Development Hong Kong, Daewoo Hong Kong and MAN Diesel & Turbo Hong Kong in various executive sales positions with increasing responsibility.
“I am excited to join PAC and help support the growth in Asia Pacifi c. I plan to focus on improving overall customer experiences and help our customers identify and solve the challenges in this dynamic Asia Pacifi c market,” said Mr Wong.
“In addition, PAC will be opening a new technical facility in the pilot free trade zone of Shanghai, China in October of this year. This fi rst class facility
Messe München International Takes Over One of India’s Leading Trade Fairs for Laboratory Technology
Messe München International is strengthening its portfolio of events in the future market of India by taking over India Lab Expo, one of the leading trade fairs for laboratory technology, analysis and biotechnology on the Indian subcontinent. For the fi rst time ever, this year’s India Lab Expo is being held under the supervision of Messe München International. It takes place at the Hitex Exhibition Centre in Hyderabad from 6–8 November. As of autumn 2015, it will be held at the same time as analytica Anacon India, which is part of the international analytica network of trade fairs.
India Lab Expo has alternated between New Delhi and Hyderabad since 2010. The last time that it was held, 252 exhibitors from 15 countries presented their latest products to 8,600 visitors from 19 countries in three halls. The majority of the exhibitors were from India. Besides representatives of the pharma industry, visitors included decision- makers and users from the chemicals, medicine and food industries. Its participants include large numbers of Indian manufacturers in the laboratory-technology sector, so it will complement analytica Anacon India perfectly. The Indian spin-off of the international trade fair analytica has a very large share of international exhibitors who above all present products for the analysis sector.
According to Dr Reinhard Pfeiffer, Deputy CEO of Messe München, the combination offers clear strategic advantages: “Taking over India Lab Expo puts us in the leading position on the Indian market for analysis, laboratory technology and biotechnology.”
31659pr@reply-direct.com
will be our centre for our regional customer training and also serve as a manufacturing and distribution centre for our instruments and spare parts to better support our Asia Pacifi c customers. This new facility is in addition to our sales offi ce at United Plaza in Shanghai.”
“We are pleased that Samuel joined PAC. His experience in building local organisations in Asia Pacifi c is going to be important for our growth in that region. As a fi rst step in building out an organisation, we are opening a new technical facility in Shanghai. From our two Shanghai locations, we will be able to fully support our customers and channel partners for all their needs, including sales, customer service, service, and operations, which will enable us to provide better service and quickly respond to our customer base in the region,” said Eric Schellenberger, PAC President.
31528pr@reply-direct.com
Celerion Establishes Business Presence in Singapore and Appoints Dr Chew Lan Chong as Executive Director
Celerion is pleased to announce the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Dr Chew Lan Chong, MBBS, MRCS, MSc as Executive Director, Medical Research. Dr Chong brings 10 years of direct operational experience leading clinical pharmacology units.
Dr Chong will lead Celerion’s business operations in Singapore, provide medical and scientifi c expertise and collaborate with partner early clinical research units to conduct complex early clinical pharmacology studies to the highest global standards.
“We are delighted to continue to build a strong footprint in Asia with our new offi ce in Singapore, headed up by Chew Lan,” said Frederick Pritchard PhD Vice President of Global Drug Development at Celerion. “The continued expansion in Asia demonstrates Celerion’s commitment to providing clients innovative solutions to conduct patient studies.”
Dr Chong brings to Celerion a wealth of operational experience, having conducted over 130 early clinical studies at organisations including Pfi zer and Lilly in Singapore. Dr Chong completed postgraduate medical training through The Royal College of Surgeons in Edinburgh. She received her medical degree from Singapore National University. In 2011, she complemented her medical training and industry experience by earning a Master’s degree in Experimental Therapeutics from The University of Oxford.
31718pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144
